Cerise Yuen‐Ki Chan
Hong Kong Science and Technology Parks Corporation(HK)University of Hong Kong(HK)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, interferon and immune responses, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma(2018)174 cited
- → Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma(2017)158 cited
- → Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer(2023)103 cited
- → HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma(2018)79 cited
- → Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses(2022)56 cited
- → CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma(2022)54 cited
- → Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development(2023)53 cited
- → Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer(2021)52 cited
- → Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity(2022)36 cited
- → Genome‐Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment(2022)33 cited